What's going on with the CSL share price on Tuesday?

The ASX biotech giant is moving along with its Vifor takeover…

| More on:
Happy healthcare workers in a labs

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • CSL shares push dip into the red in early trade in line with a fall across the ASX 200 index 
  • The company announced that it has met all regulatory approvals for the Vifor acquisition which will be finalised by 9 August (next Tuesday)
  • CSL also appointed Hervé Gisserot as the general manager of Vifor once the takeover is complete

The CSL Ltd (ASX: CSL) share price is edging lower in early trading amid the company's latest update on its Vifor acquisition.

At the time of writing, shares in the global biotech are down slightly by 0.27% to $294.10.

Meantime, the S&P/ASX 200 Index (ASX: XJO) is also hovering 0.36% lower to 6,967.6 points.

What did CSL announce to the ASX?

In its announcement, CSL advised it has received all regulatory clearances to finalise the acquisition of Vifor Pharma, effective today.

This comes after the lengthy delay earlier this year regarding the foreign direct investment and regulatory filings.

Nonetheless, with all conditions now met, the takeover of the global specialty pharmaceuticals company will take place by 9 August.

CSL expects to hold more than 97% of Vifor shares upon completion and will seek to cancel the remaining 3%. This will be in accordance with Swiss takeover rules, with CSL also applying for the delisting of these shares on the Swiss Exchange (SIX).

CSL CEO and managing director Paul Perreault commented:

We are excited to complete the acquisition of Vifor Pharma — enhancing CSL's well-established patient focus and ability to protect the health of those facing a range of rare and serious medical conditions.

Perreault went on to add:

Joining CSL, the Vifor business adds near-term value along with a clear path to long-term sustainable growth. It also adds an outstanding management team, along with a high-value and complementary portfolio of products and market leading position in the nephrology and iron deficiency spaces.

Investors may want to keep an eye out on 17 October as CSL will hold a dedicated Vifor market briefing. Management will discuss Vifor's growth strategy and insights into its product portfolio and financials.

CSL appoints general manager for Vifor

In other news, CSL has appointed Hervé Gisserot as general manager for the Vifor business once the acquisition is finalised.

Reporting directly to Perreault, the appointment of Gisserot should be a smooth transition given his credentials and current position.

Since January 2022, Gisserot has been the chief commercial officer for Vifor Pharma.

Previously, he spent 13 years at GlaxoSmithKline fulfilling multiple senior vice president (SVP) titles. This includes the most recent, SVP & Head of Pharmaceuticals & Vaccines for Greater China & Intercontinental.

CSL share price snapshot

Despite the recent market volatility, the CSL share price has outperformed the market to surge almost 10% in a month.

For context, the benchmark ASX 200 index has lifted around 7% over the same time frame.

CSL is the third largest company on the ASX with a market capitalisation of roughly $142 billion.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A female stockbroker reviews share price performance in her office with the city shown in the background through her windows
Share Market News

5 things to watch on the ASX 200 on Friday

Another good session is expected for Aussie investors today. Here's what is happening.

Read more »

A middle-aged man working from home looks at his mobile phone with a laptop open on the table in front of him.
Share Market News

Here's why more Australians intend to work during retirement

A new survey reveals insights into the retirement intentions of older Australian workers.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Share Market News

Are we soon to see a skyrocketing Aussie stock market?

Will the Aussie stock market follow the lead of American stock markets following the US election?

Read more »

A man and a woman sit in front of a laptop looking fascinated and captivated.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a volatile, but positive, day for ASX shares this Thursday.

Read more »

A cloud with a blue arrow pointing upwards through its middle symbolising a rising asx share price
Record Highs

Xero and 2 other ASX tech shares cracking all-time highs on Thursday

The price peaks follow a significant lift in the NASDAQ overnight following Republican Donald Trump's US election victory.

Read more »

A US flag behind a graph, indicating investment in US shares
Share Market News

What the US election outcome means for ASX shares

ASX shares are having a mixed reaction to the US election results today.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Share Gainers

Why Block, GQG, Neuren, and Sigma shares are racing higher today

These shares are rising on Thursday. But why?

Read more »

A woman with short brown hair and wearing a yellow top looks at the camera with a puzzled and shocked look on her face as the Westpac share price goes down for no reason today
Share Fallers

Why Clearview, NAB, Resolute Mining, and Westpac shares are dropping today

These shares are under pressure today. But why?

Read more »